Co-Authors
This is a "connection" page, showing publications co-authored by François Mullier and Yves Gruel.
Connection Strength
0.929
-
Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins - a rational for monitoring immunoglobulin G levels. Haematologica. 2021 08 12.
Score: 0.240
-
Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thromb Res. 2021 07; 203:163-171.
Score: 0.236
-
[Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?] Ann Biol Clin (Paris). 2020 10 01; 78(5):471-481.
Score: 0.226
-
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory. Thromb J. 2020; 18:17.
Score: 0.225